Are stomach balloons the future of weight loss?

Posted on

Obesity is among the very serious health issues worldwide. At the U.S., a whopping 1 in 3 adults is deemed obese, and 2 in 3 are overweight or overweight from clinical definitions. It is projected that by 2030 more than half of the planet’s population will be overweight or overweight. Associated health issues include specific kinds of cancer, type II diabetes, cardiovascular disease, non-alcoholic fatty liver infection, osteoporosis, and higher blood pressure.

Despite wide acceptance by doctors, weight loss surgery such as the gastric bypass procedure was largely rejected by health care customers. Just 1 to 2 percent of individuals who qualify for weight loss surgery decide to get it. For the other 99 percent, the concept of permanently transforming their bodies and the chance of life-threatening complications are not worth the possibility of weight reduction.

Other consumers are discouraged by how hard it’s to receive insurance coverage for weight loss processes. Many need to appeal many times prior to getting acceptance, and several are never accepted in any respect. And many Americans do not possess the $23,000 it might cost to cover gastric bypass operation from the pockets.

Stomach balloons (also called gastric balloons), a much less invasive, more economical weight loss therapy, are increasing in popularity.

The balloon takes up space in the belly to help patients adapt to healthier part sizes. The balloon remains in position for six weeks, that is supposed to be long enough to alter the eating habits of the majority of patients.

During those six months, patients also get lifestyle and diet counseling to help them get the maximum from this process. Following the balloon is removed, patients continue having the following six months of counseling to assist them keep the weight they have lost.

In 1 study patients that had received ORBERA, the common gastric balloon apparatus, lost a mean of 21.8 lbs while the apparatus was set up and maintained a weight loss average of 19.4 lbs in the six months following elimination. Comparatively, patients that did not obtain a device but engaged in the weight reduction counseling component of this program dropped an average of seven pounds.

According to the FDA, the device should only be used by overweight adults who have a BMI of 30-40 who have not been able to get rid of weight through other procedures, including exercise and diet. While the unit is thought to be a safe choice for people who are clinically overweight, there are risks with any medical procedure.

A survey of 160 patients utilizing the ORBERA device revealed a 10 percent rate of severe adverse incidents. These incidents included dehydration, illness, and gastric perforation with sepsis, however, the most common serious adverse event was apparatus intolerance, defined as excruciating nausea, vomiting, or reflux pain which resulted in early apparatus removal. Because FDA approval there also have been reports of acute pancreatitis and spontaneous over-inflation, but those incidents are very rare.

Many physicians think that the hazards related to obesity are greater than the risks associated with this process. And to place the gastric balloon apparatus in outlook, most studies report that a considerably higher rate of severe adverse incidents for gastric bypass surgery.

If you are worried about your weight, speak with your physician about the way you live first. Most physicians consider weight reduction processes a last resort and will urge exercise, diet, and nutritional counseling prior to advocating any sort of medical procedure.

Leave a Reply

Your email address will not be published. Required fields are marked *